A commercial radioimmunoassay kit was evaluated for efficacy in detecting methaqualone or its metabolites in urine of persons receiving this drug. The drug and its unconjugated 3'-and 4'-monohydroxy metabolites could be detected equally well. The unconjugated a-monohydroxy metabolite was about 80% as reactive and the unconjugated 6-monohydroxy metabolite reacted only very weakly. Quantitation of the conjugated metabolites was less sensitive than of unconjugated. Nineteen urine specimens which reacted positively to radioimmunoassay and which thin-layer chromatography had shown to contain methaqualone and its metabolites were also examined by gas-liquid chromatography. Those specimens that reacted strongly to radloimmunoassay contained high concentrations of the drug or its metabolites. In the specimens examined by gas-liquid chromatography, the apparent concentrations of the metabolites were generally higher than those of the drug itself. Methaqualone in combination with its unconjugated metabolites reacted additively with the radioimmunoassay, resembling the same concentration of parent drug alone. Detection limits were between 10-200 pig/liter. Addftlonal K.yphrases drug assay #{149} inter-method comparison #{149} relative assay responsiveness to parent drug and metabolites
Radioimmunoassay of Methaqualone and Its Monohydroxy Metabolites in Urine
Ann R. Berman, James P. McGrath, Robert C. Permisohn, and James A. Celia A commercial radioimmunoassay kit was evaluated for efficacy in detecting methaqualone or its metabolites in urine of persons receiving this drug. The drug and its unconjugated 3'-and 4'-monohydroxy metabolites could be detected equally well. The unconjugated a-monohydroxy metabolite was about 80% as reactive and the unconjugated 6-monohydroxy metabolite reacted only very weakly. Quantitation of the conjugated metabolites was less sensitive than of unconjugated. Nineteen urine specimens which reacted positively to radioimmunoassay and which thin-layer chromatography had shown to contain methaqualone and its metabolites were also examined by gas-liquid chromatography. Those specimens that reacted strongly to radloimmunoassay contained high concentrations of the drug or its metabolites. In the specimens examined by gas-liquid chromatography, the apparent concentrations of the metabolites were generally higher than those of the drug itself. Methaqualone in combination with its unconjugated metabolites reacted additively with the radioimmunoassay, resembling the same concentration of parent drug alone. Detection limits were between 10-200 pig/liter. 
Materials and Methods

Apparatus
Procedure
Standard curves were prepared from Roche Diagnostics' RIA kit for methaqualone detection, by using dilutions of the positive control urine (100 ig/1iter) supplied with the kit to give concentrations of 1, 10, 20, 50, and 100 ig of methaqualone per liter. The diluent was the normal control urine supplied in the kit.
We also prepared a standard curve by using methaqualone free base in pooled drug-free urine in concentrations of 1, 10, 20, 50, 100, 200, 500, 1000 ag/liter, and similar curves were prepared with each of the four synthetic metabolites.
Another curve was prepared by using a mixture of methaqualone and four metabolites in equal concentrations such that the total combined concentration of the five components ranged from 1 to 1000 ag/liter, as above.
We compared all these curves to that for methaqualone free base.
The samples were analyzed by RIA in triplicate according to the procedures described in the protocol accompanying the commercial kit, and with use of the supplied methaqualone antiserum and 1251-labeled methaqualone.
The methaqualone or metabolite solutions (0.1 ml) were placed in 12 X 75 mm disposable glass tubes. Methaqualone antiserum, 0.2 ml, and 1251-labeled methaqualone, 0.2 ml, were added to each tube, the contents mixed, and the tubes incubated at room temperature for 1 h. Saturated ammonium sulfate solution, 0.5 ml, was then added to each tube. The sample tubes were vortex-mixed and kept at room temperature for 10 mm, to precipitate the globulins and bound antigen, then centrifuged (1000 x g, 10 mm) in a swinging bucket rotor. Volumes of 0.5 ml of the supernatant solutions, which contained the unbound '25I-methaqualone, were pipetted into 12 X 75 mm disposable glass tubes, stoppered, and counted for 1 mm each in the automatic gamma spectrometer. The a'erage count per minute of each triplicate sample group was used in plotting the curves.
Nineteen urine samples obtained from the USAFE Drug Abuse Laboratory were shown to be positive for methaqualone by RIA and confirmed by GLC. The concentrations of drug and metabolites were quantitated by RIA and GLC for comparison.
We processed these urine samples for immunoassay in the same manner as the methaqualone standards, using 0.1 ml of sample after appropriate dilution in distilled water to obtain results on the linear portion of the standard curve.
Specimens were prepared for gas-chromatographic analysis by a modification of the method of Bonnichsen et a!. (7). Acid-hydrolyzed urine was extracted at an alkaline pH (8.5) followed by a phosphate buffer (pH 8.5) wash. Aliquots of the chloroform extracts were evaporated under nitrogen and the residue, in 50 sl of dimethyl formamide, was treated with 50 tl of N,O-bis(trimethylsilyl)acetamide to form the tnmethylsilyl derivatives.
An aliquot of a single urine sample obtained from a volunteer after he had ingested 300 mg of methaqualone was hydrolyzed with NaIO4 according to the method of Burnett et a!. (3) . Samples of hydrolyzed and unhydrolyzed urine from this same specimen were quantitated (results expressed in terms of methaqualone equivalents) by RIA, to compare the sensitivity of the method for conjugated and unconjugated metabolites.
Sample 10-, 30-, and 100-fold dilutions were made in distilled water because of the high concentrations of methaqualone equivalents previously found with RIA. Ten replicates of each a!-iquot of the specimen were processed for immunoassay according to the kit protocol.
Results
The methaqualone curve produced by use of the commercial kit reagents agreed well with that obtained with methaqualone free base (Figure 1) . A methaqualone response curve supplied by the vendor with the RIA kit was extended to a concentration of 500 big/liter. It correlated well with the curve we prepared by use of methaqualone free base. Figure 2 shows the reactivities of the four unconjugated hydroxylated metabolites and the parent drug. The 4'-OH metabolite and methaqualone were the most reactive, the 3'-OH metabolite was slightly less reactive, and the a-OH metabolite was about 80% as reactive as methaqualone.
The 6-OH metabolite did not react significantly with the reagents. The corn- bined metabolites and methaqualone curve was very similar to the curve for methaqualone free base alone (Figure 3) . Table 1 shows the greater sensitivity in immunoassay of the free metabolites of methaqualone than of the conjugated metabolites.
That is to say, the hydrolyzed urine sample, in which metabolites were free, gave higher values than did the unhydrolyzed urine containing the conjugated metabolites. Table 2 compares results by RIA and GLC. There was relatively good agreement between the two methods, with a few exceptions. Evidently, lit all cases the components in greatest concentration associated with positive responses by RIA were the metabolites.
Discussion
Methaqualone is transported in human plasma principally in protein-bound form after absorption from the gastrointestinal tract (11, 12) . In mice it is rapidly taken up by adipose tissue, liver, and brain Because so little of the unchanged drug is excreted in the urine (15, 16) , the ability to detect methaqualone metabolites is obviously important for drugscreening procedures. Figure 3 compares the binding characteristics of methaqualone free base, alone and in combination with equal concentrations of the four metabolites, and shows that this combination of drug and its metabolites has nearly the same avidity for the antibody as does the parent compound alone and is additive in its effect on results.
The RIA for methaqualone cannot distinguish between the drug and its metabolites.
Results are therefore expressed as methaqualone equivalents and include both the drug and any of its derivatives that are present in the specimens. Therefore, because of the low concentration of parent drug in urine, it is important to know that the rnetabolites will react with the RIA in a specific and sensitive manner.
Even though the free metabolites react more strongly than do the conjugated metabolites (Table  1) , the results in either case are sensitive and specific enough to validate the immunoassay procedure. Results by RIA and GLC correlate reasonably well (Table 2) . When methaqualone or its metabolites were detected by RIA in these urine samples, this was confirmed by GLC. The results of GLC, as shown in Table 2 , enable one to distinguish the parent drug from the estimated mathematical total of the four principal metabolites.
The concentrations of unmetabolized drug were low, and concentrations of the total metabolites greatly exceeded that of the parent drug in each positive urine sample.
Previous evaluation of the RIA kit for large volume drug screening done in our laboratory revealed no cross-reactivity with other drugs of abuse. These included samples containing as much as 250 mg of morphine, barbiturates, methadone, or amphetamine per liter, which were diluted in known drug-free urine specimens.
We have demonstrated that the RIA for methaqualone is both specific and sensitive, revealing both the drug and two of its major metabolites in urine. Reactivities of the other two major metabolites appear to be weaker, but are still additive in the immunoassay test.
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